Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1885821Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$1.5M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#5,037
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Matthew Lawrence Springer as a PI. Multi-PI records show the full award amount for context.
- 5R01HL174690-03R01Cardiovascular Effects of Inhalable Tobacco Product Dual Use$807.5Kaward amount
- 5R01DA058069-04R01Effects of chronic marijuana use on endothelial function$719.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Matthew Lawrence Springer as a PI.
FY2026 award administered by University of California, San Francisco (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California, San Francisco
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #8363
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder